Summary of Purpose
To determine the clinical efficacy and safety of intra-arterial Urokinase in patients with acute MCA stroke of less than 6 hours duration.Read More →
The following dates are available for this trial. Trial information last updated on 1 April 2009.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- The Japanese Ministry of Health, Welfare, and Labor
Prospective, randomized, controlled, multicenter, open-label clinical trial with blinded follow-up.